Investor profile
Orlando Health Ventures
Corporate investor
Orlando, FL
Directory portfolio
Companies connected here
2
Latest company funding first, including rounds involving other investors. Unknown dates last.
410 Medical
Latest company funding · Jul 14, 2026
LifeFlow rapid fluid infusion devices
- A
Arrivo BioVentures
Latest company funding · —
Clinical-stage drug developer with two candidates: forvisirvat (SP-624), a SIRT6 activator in Phase 2b/3 for major depressive disorder, and RABI-767 for predicted severe acute pancreatitis.
Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.